Constipation in specialized palliative care: factors related to constipation when applying different definitions.
2016 (English)In: Supportive Care in Cancer, ISSN 0941-4355, E-ISSN 1433-7339, Vol. 24, no 2, 691-698 p.Article in journal (Refereed) Published
For patients in palliative care, constipation is primarily a result of opioid treatment. Impacts from other factors related to constipation in palliative care are rarely studied.
The aim was to identify factors related to constipation in patients in palliative care, and then to compare these factors between patients with different types of constipation and patients without constipation.
Cross-sectional data on constipation was collected with a 26-item questionnaire from 485 patients in 38 specialist palliative care units in Sweden. Three different constipation groups were used; MC ONLY, PC ONLY, and MC & PC. Logistic regression analyses were used to calculate odds ratios.
Patients with <3 defecations/week, MC ONLY, (n = 36) had higher odds of being hospitalized, bed-restricted, in need of personal assistance for toilet visits, and of having a poor fluid intake. Patients with the perception of being constipated, PC ONLY, (n = 93) had higher odds of having poor appetite, hemorrhoids, hard stool, more opioid treatment, less laxative treatment and of being more dissatisfied with constipation information. Patients with both <3 defecations/week and a perception of being constipated, MC & PC, (n = 78) had higher odds of having cancer- disease.
There were several significant factors related to constipation with higher odds than opioid- treatment, for patients in palliative care, such as; hard stool, cancer diagnosis, dissatisfaction with information, low fluid intake, hemorrhoids, bed restriction, hospitalization, and need of personal assistance for toilet visits.
Place, publisher, year, edition, pages
Springer Berlin/Heidelberg, 2016. Vol. 24, no 2, 691-698 p.
Constipation; Palliative care; Risk factors; Symptom assessment
IdentifiersURN: urn:nbn:se:liu:diva-121720DOI: 10.1007/s00520-015-2831-5ISI: 000367458200022PubMedID: 26160464OAI: oai:DiVA.org:liu-121720DiVA: diva2:858643
FunderMedical Research Council of Southeast Sweden (FORSS), 228731
Funding agencies: Medical Research Council of Southeast Sweden (FORSS); Vrinnevi Hospital Research Board2015-10-022015-10-022016-02-02Bibliographically approved